5 months ago
BCRX
AnalystsJonathan WollebenJonathan Wolleben's Stock Forecasts
AnalystsJonathan Wolleben
Analyst Ranking
Top 3%
#125 out of 5223 analysts
Average Return
+18.4%
Win Rate
49%123 out of 251
Risk vs Reward
Poor
Good
Jonathan Wolleben's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dbv Technologies SaDBVT | +408.60% | $4.30 | $21.87 | 2025-03-04 - 2026-03-03 | Buy |
Dbv Technologies SaDBVT | +397.39% | $3.45 | $17.16 | 2024-12-10 - 2025-12-09 | Buy |
Madrigal Pharmaceuticals IncMDGL | +365.01% | $64.44 | $299.65 | 2022-05-10 - 2023-05-09 | Buy |
Mbx Biosciences IncMBX | +357.42% | $6.27 | $28.68 | 2025-04-10 - 2026-03-20 | Buy |
Dbv Technologies SaDBVT | +242.25% | $4.97 | $17.01 | 2025-01-10 - 2026-01-09 | Buy |
Jonathan Wolleben Analyst Color
Get additional color on Jonathan Wolleben's coverage of popular stocks
5 months ago
BCRX
a year ago
SPOT
Jonathan Wolleben's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals IncRYTM | 9 | Buy | $155.00 | +77.24% | Maintains | 3 days ago |
Spruce Biosciences IncSPRB | 9 | Buy | $170.00 | +191.10% | Maintains | 13 days ago |
Crinetics Pharmaceuticals IncCRNX | 19 | Buy | $96.00 | +169.89% | Maintains | 21 days ago |
Structure Therapeutics IncGPCR | 12 | Buy | $113.00 | +132.56% | Maintains | 24 days ago |
Protagonist Therapeutics IncPTGX | 14 | Buy | $112.00 | +13.28% | Maintains | 25 days ago |
Mirum Pharmaceuticals IncMIRM | 14 | Buy | $132.00 | +49.14% | Maintains | 25 days ago |
Sionna Therapeutics IncSION | 1 | Buy | $63.00 | +73.12% | Initiates Coverage On | a month ago |
Madrigal Pharmaceuticals IncMDGL | 13 | Buy | $745.00 | +68.87% | Maintains | 2 months ago |
Dbv Technologies SaDBVT | 16 | Buy | $45.00 | +135.73% | Maintains | 3 months ago |
Sagimet Biosciences IncSGMT | 9 | Buy | $35.00 | +626.14% | Maintains | 4 months ago |
Savara IncSVRA | 10 | Buy | $10.00 | +101.61% | Maintains | 4 months ago |
Kalvista Pharmaceuticals IncKALV | 6 | Buy | $28.00 | +64.71% | Maintains | 4 months ago |
Altimmune IncALT | 13 | Buy | $14.00 | +319.16% | Maintains | 5 months ago |
Biocryst Pharmaceuticals IncBCRX | 10 | Buy | $25.00 | +157.73% | Maintains | 5 months ago |
Kalaris Therapeutics IncKLRS | 1 | Buy | $20.00 | +204.41% | Initiates Coverage On | 5 months ago |
Ocular Therapeutix IncOCUL | 16 | Buy | $29.00 | +254.52% | Maintains | 6 months ago |
Larimar Therapeutics IncLRMR | 13 | Buy | $18.00 | +300.89% | Reiterates | 7 months ago |
Pharvaris NvPHVS | 12 | Buy | $52.00 | +100.00% | Maintains | 7 months ago |
Astria Therapeutics IncATXS | 3 | Buy | $26.00 | +106.68% | Maintains | 7 months ago |
Quince Therapeutics IncQNCX | 2 | Buy | $8.00 | +9,900.00% | Maintains | 7 months ago |
Proqr Therapeutics NvPRQR | 6 | Buy | $8.00 | +419.48% | Reiterates | 9 months ago |
Skye Bioscience IncSKYE | 3 | Buy | $15.00 | +2,211.25% | Reiterates | 9 months ago |
Aura Biosciences IncAURA | 9 | Buy | $19.00 | +190.08% | Reiterates | 10 months ago |
Clearside Biomedical IncCLSDQ | 11 | Buy | $75.00 | +18,192.68% | Reiterates | 10 months ago |
Mbx Biosciences IncMBX | 1 | Buy | $38.00 | +32.50% | Initiates Coverage On | a year ago |
Hilton Grand Vacations IncHGV | 1 | Buy | $50.00 | N/A | Maintains | a year ago |
Costar Group IncCSGP | 1 | Buy | $90.00 | N/A | Reiterates | a year ago |
Spotify Technology SaSPOT | 1 | Buy | $485.00 | N/A | Downgrades | a year ago |
Allakos IncALLK | 6 | Buy | $3.00 | N/A | Reiterates | a year ago |
Rallybio CorpRLYB | 11 | Buy | $64.00 | N/A | Reiterates | 2 years ago |
Warner Music Group CorpWMG | 1 | Buy | $24.00 | N/A | Maintains | 3 years ago |
Strongbridge Biopharma PLCSBBP | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.